July 05, 2022
1 min learn
The White Home lately introduced plans to develop monkeypox vaccination eligibility in the US.
The monkeypox vaccine is now accessible to anybody who has been at a venue the place the sickness has been reported and to males who’ve intercourse with males who’ve had a number of intercourse companions in a venue the place there may be recognized to have been monkeypox or in an space the place it’s spreading. It was the highest story in infectious illness final week.
One other high story was about an announcement from the FDA that COVID-19 vaccine producers ought to add a spike protein part for omicron subvariants to present vaccines to create bivalent boosters. The FDA made the announcement days after an advisory committee voted 19-2 in favor of the change.
Learn these and extra high tales in infectious illness under:
With instances growing, US expands entry to monkeypox vaccine
U.S. well being officers introduced a brand new plan to broaden entry to monkeypox vaccines amid a continued rise in instances. Read more.
FDA says vaccine makers ought to add omicron to COVID-19 boosters
The FDA has advised COVID-19 vaccine producers that they need to add a spike protein part for the omicron subvariants BA.4 and BA.5 to their present vaccines to create bivalent boosters. Read more.
FDA advisors vote in favor of including omicron to COVID-19 boosters
An FDA advisory committee voted to advocate altering the composition of COVID-19 booster vaccines to incorporate the addition of the omicron variant of SARS-CoV-2 as a part. Read more.
Q&A: NIH expands COVID-19 knowledge accessible to researchers
Not too long ago, the NIH introduced that its All of Us Analysis Program would develop the COVID-19 knowledge which can be accessible to researchers in the US. Read more.
New knowledge counsel pandemic disruptions led to drop in HIV testing
New knowledge confirmed a pointy lower in CDC-funded HIV assessments administered in well being care and non-health care settings from 2019 to 2020 — primarily amongst teams disproportionately affected by HIV. Read more.